Valeant Pharmaceuticals raised its offer to buy Botox maker Allergan, increasing the cash portion of its bid and lifting its overall value to more than $49 billion.
via WSJ.com: US Business http://ift.tt/1nU7dfq
via WSJ.com: US Business http://ift.tt/1nU7dfq
Nessun commento:
Posta un commento